Key Analysts at DA Davidson Didn’t Change their ‘”Buy”’ rating for Medifast (NYSE:MED) Shares Today. Their PT is Set to $74

September 17, 2017 - By Marguerite Chambers

 Key Analysts at DA Davidson Didn't Change their ‘

Investors sentiment decreased to 1.11 in 2016 Q4. Its down 0.30, from 1.41 in 2016Q3. It worsened, as 12 investors sold Medifast Inc shares while 53 reduced holdings. 19 funds opened positions while 53 raised stakes. 10.30 million shares or 1.41% more from 10.16 million shares in 2016Q3 were reported.

Brown Advisory Incorporated holds 10,115 shares. Td Asset Mngmt has 0% invested in Medifast Inc (NYSE:MED) for 24,600 shares. State Of Alaska Department Of Revenue stated it has 1,210 shares. Moreover, Wellington Grp Inc Ltd Liability Partnership has 0% invested in Medifast Inc (NYSE:MED). Bessemer Group has invested 0% in Medifast Inc (NYSE:MED). Secor Cap Ltd Partnership has 0.06% invested in Medifast Inc (NYSE:MED). Hl Fincl Services Ltd Limited Liability Company has 7,969 shares. Mufg Americas Holdings Corporation holds 0% or 148 shares. Numeric Invsts Ltd has 474,898 shares for 0.21% of their portfolio. Parametric Assocs Lc stated it has 0% in Medifast Inc (NYSE:MED). Blackrock Investment Mngmt Ltd Company has invested 0% in Medifast Inc (NYSE:MED). Susquehanna Group Llp accumulated 40,866 shares or 0% of the stock. The New York-based First Manhattan has invested 0% in Medifast Inc (NYSE:MED). Cambridge Advisors holds 0% or 5,082 shares in its portfolio. Eqis Mngmt reported 0.04% stake.

Medifast (NYSE:MED) Rating Reaffirmed

The broker has just set a TP of $74 on Medifast (NYSE:MED) shares. This is 31.02 % from the last price. In analysts note sent to clients and investors on 15 September, DA Davidson maintained their “Buy” rating on shares of MED.

Investors sentiment decreased to 1.11 in 2016 Q4. Its down 0.30, from 1.41 in 2016Q3. It worsened, as 12 investors sold Medifast Inc shares while 53 reduced holdings. 19 funds opened positions while 53 raised stakes. 10.30 million shares or 1.41% more from 10.16 million shares in 2016Q3 were reported.

Brown Advisory Incorporated holds 10,115 shares. Td Asset Mngmt has 0% invested in Medifast Inc (NYSE:MED) for 24,600 shares. State Of Alaska Department Of Revenue stated it has 1,210 shares. Moreover, Wellington Grp Inc Ltd Liability Partnership has 0% invested in Medifast Inc (NYSE:MED). Bessemer Group has invested 0% in Medifast Inc (NYSE:MED). Secor Cap Ltd Partnership has 0.06% invested in Medifast Inc (NYSE:MED). Hl Fincl Services Ltd Limited Liability Company has 7,969 shares. Mufg Americas Holdings Corporation holds 0% or 148 shares. Numeric Invsts Ltd has 474,898 shares for 0.21% of their portfolio. Parametric Assocs Lc stated it has 0% in Medifast Inc (NYSE:MED). Blackrock Investment Mngmt Ltd Company has invested 0% in Medifast Inc (NYSE:MED). Susquehanna Group Llp accumulated 40,866 shares or 0% of the stock. The New York-based First Manhattan has invested 0% in Medifast Inc (NYSE:MED). Cambridge Advisors holds 0% or 5,082 shares in its portfolio. Eqis Mngmt reported 0.04% stake.

Medifast Inc (NYSE:MED) Ratings Coverage

Among 3 analysts covering Medifast (NYSE:MED), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Medifast has $74 highest and $32 lowest target. $53’s average target is -6.16% below currents $56.48 stock price. Medifast had 7 analyst reports since August 10, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Sidoti on Monday, November 30. The rating was initiated by DA Davidson on Wednesday, August 16 with “Buy”. The company was upgraded on Monday, January 11 by Sidoti. Zacks downgraded Medifast Inc (NYSE:MED) on Monday, August 10 to “Hold” rating. The firm earned “Buy” rating on Friday, September 15 by DA Davidson. Wunderlich initiated Medifast Inc (NYSE:MED) rating on Friday, January 29. Wunderlich has “Hold” rating and $32 target. The stock has “Buy” rating by Sidoti on Monday, October 5.

The stock increased 3.03% or $1.66 on September 15, reaching $56.48. About 297,800 shares traded or 112.67% up from the average. Medifast Inc (NYSE:MED) has risen 25.81% since September 17, 2016 and is uptrending. It has outperformed by 9.11% the S&P500.

Analysts expect Medifast Inc (NYSE:MED) to report $0.51 EPS on November, 2.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $0.51 EPS. MED’s profit would be $6.08 million giving it 27.69 P/E if the $0.51 EPS is correct. After having $0.63 EPS previously, Medifast Inc’s analysts see -19.05 % EPS growth.

Medifast, Inc. is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. The company has market cap of $673.81 million. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins. It has a 28.36 P/E ratio. The Firm provides weight loss, weight management and healthy living products and programs through multiple channels of distribution, which include Take Shape For Life; its direct to consumer business unit through its Website and in-house call centers; Franchise Medifast Weight Control Centers, and a national network of physicians.

More important recent Medifast Inc (NYSE:MED) news were published by: Prnewswire.com which released: “Medifast, Inc. Announces Quarterly Dividend” on August 08, 2017, also Prnewswire.com published article titled: “Medifast, Inc. Announces First Quarter 2017 Financial Results”, Seekingalpha.com published: “Medifast Is Overweight With Inventory. Will Margins Slim Down?” on June 01, 2017. More interesting news about Medifast Inc (NYSE:MED) was released by: Prnewswire.com and their article: “Medifast, Inc. Announces Second Quarter 2017 Financial Results” with publication date: August 08, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.